STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] CeriBell, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Joseph M. Taylor, a director of Ceribell, Inc. (CBLL), reported the sale of 7,032 shares of Common Stock on 08/19/2025 at a weighted-average price of $11.76. After the reported disposition, the filing shows the reporting person beneficially owned 59,235 shares. The Form 4 was filed as a single reporting-person filing and was signed by an attorney-in-fact.

Positive
  • Required disclosure provided: The Form 4 reports the insider sale and ending beneficial ownership, meeting SEC disclosure obligations
  • Detailed pricing footnote: The filing explains the weighted-average price and price range ($11.75 to $11.81) for the multiple transactions
Negative
  • Insider sold shares: A director disposed of 7,032 shares, reducing his beneficial holdings to 59,235 shares
  • No stated reason or plan: The filing does not indicate whether the sale was pursuant to a prearranged plan or the purpose of the transactions

Insights

TL;DR: Director sale of 7,032 shares at $11.76 reduces insider stake but appears routine; disclosure supplied via Form 4.

The reported transaction is a straightforward insider sale: 7,032 common shares were disposed of on 08/19/2025 at a weighted-average price of $11.76, with the reporting person retaining 59,235 shares after the sale. There is no other financial or contextual information in the filing about purpose, planned trading program, or any derivative activity. For investors, the filing documents the change in beneficial ownership but does not by itself indicate a material change in company fundamentals.

TL;DR: The filing documents a director sale and provides the required disclosure; no governance red flags are evident from this Form 4 alone.

The Form 4 identifies the reporting person as a director and records multiple sale transactions aggregated to 7,032 shares at a weighted-average price between $11.75 and $11.81. The filing includes the explanatory footnote about price ranges and was signed via attorney-in-fact. The form contains no indications of 10b5-1 plan reliance or unusual transactions; absent additional filings or context, this appears to be a routine reported disposition.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Taylor Joseph Michael

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/19/2025 S 7,032 D $11.76(1) 59,235 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
/s/ Louisa Daniels, Attorney-in-Fact for Joseph M. Taylor 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did the Form 4 for CBLL report?

The Form 4 reports a sale of 7,032 Common Stock shares by Joseph M. Taylor on 08/19/2025.

At what price were the CBLL shares sold in the reported transaction?

The shares were sold at a weighted-average price of $11.76, with transaction prices ranging from $11.75 to $11.81.

How many Ceribell (CBLL) shares does the reporting person own after the sale?

The filing shows 59,235 shares beneficially owned following the reported dispositions.

Who filed the Form 4 for Ceribell (CBLL)?

The Form 4 was filed for Joseph M. Taylor, identified as a director, and the signature was by an attorney-in-fact.

Does the Form 4 indicate the sale was part of a 10b5-1 trading plan?

No. The filing does not indicate that the transactions were made pursuant to a 10b5-1 plan.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

436.99M
29.22M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE